New hope for young hearts: testing a safer blood thinner dose
NCT ID NCT06978439
Summary
This small pilot study is testing a specific, lower dose of the blood thinner rivaroxaban in Chinese children who have developed a giant bulge (aneurysm) in their heart arteries after Kawasaki disease. The goal is to see if this dose is safe and effective at preventing dangerous blood clots in these fragile arteries. Researchers will follow 10 children for over 6 months to check for clots, bleeding, and how the drug works in their bodies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KAWASAKI DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital of Fudan University
RECRUITINGShanghai, Shanghai Municipality, 201102, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.